Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 4,690,000 shares, a growth of 19.0% from the March 31st total of 3,940,000 shares. Currently, 5.2% of the shares of the stock are sold short. Based on an average daily volume of 901,700 shares, the short-interest ratio is presently 5.2 days.
Alignment Healthcare Stock Down 2.5 %
NASDAQ:ALHC opened at $5.08 on Tuesday. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 1.02. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $9.20. The stock’s fifty day simple moving average is $5.19 and its 200-day simple moving average is $6.58. The firm has a market capitalization of $960.02 million, a P/E ratio of -6.43 and a beta of 1.30.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last issued its earnings results on Tuesday, February 27th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.03). Alignment Healthcare had a negative return on equity of 75.64% and a negative net margin of 8.12%. The company had revenue of $465.39 million for the quarter, compared to the consensus estimate of $444.56 million. During the same quarter last year, the business posted ($0.31) EPS. Alignment Healthcare’s quarterly revenue was up 28.6% on a year-over-year basis. Equities research analysts expect that Alignment Healthcare will post -0.6 earnings per share for the current year.
Analysts Set New Price Targets
Get Our Latest Research Report on ALHC
Insider Activity
In related news, insider Dawn Christine Maroney sold 23,000 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $5.44, for a total transaction of $125,120.00. Following the completion of the sale, the insider now owns 1,830,008 shares in the company, valued at approximately $9,955,243.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Alignment Healthcare news, CFO Robert Thomas Freeman sold 11,858 shares of the business’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $4.89, for a total value of $57,985.62. Following the transaction, the chief financial officer now owns 898,228 shares of the company’s stock, valued at $4,392,334.92. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Dawn Christine Maroney sold 23,000 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $5.44, for a total value of $125,120.00. Following the sale, the insider now owns 1,830,008 shares in the company, valued at approximately $9,955,243.52. The disclosure for this sale can be found here. In the last quarter, insiders have sold 90,213 shares of company stock worth $460,587. Corporate insiders own 6.30% of the company’s stock.
Institutional Trading of Alignment Healthcare
A number of large investors have recently made changes to their positions in ALHC. Allspring Global Investments Holdings LLC grew its stake in Alignment Healthcare by 9.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock valued at $196,000 after acquiring an additional 3,334 shares during the period. Principal Financial Group Inc. acquired a new position in shares of Alignment Healthcare in the 1st quarter valued at approximately $57,000. Assenagon Asset Management S.A. increased its stake in Alignment Healthcare by 283.9% during the 1st quarter. Assenagon Asset Management S.A. now owns 315,629 shares of the company’s stock worth $1,566,000 after purchasing an additional 233,417 shares in the last quarter. Aigen Investment Management LP increased its stake in Alignment Healthcare by 18.5% during the 4th quarter. Aigen Investment Management LP now owns 19,764 shares of the company’s stock worth $170,000 after purchasing an additional 3,092 shares in the last quarter. Finally, Jump Financial LLC acquired a new stake in Alignment Healthcare during the 4th quarter worth approximately $575,000. Institutional investors own 86.19% of the company’s stock.
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Read More
- Five stocks we like better than Alignment Healthcare
- Why Invest in High-Yield Dividend Stocks?
- The 3 Hottest Insiders Buys This Month
- 3 Best Fintech Stocks for a Portfolio Boost
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.